glp 1 for autoimmune 📢 “Our findings suggest that #antidiabetic drug classes may be differentially associated with incident #autoimmune disease risk,” said @jeffsparks. #GLP1 Read the full story here👇 Exploring glucagon-like peptide-1 receptor agonists

Many practitioners in the optimization space consider anything above 1.0 as something to address

37 Although hepatic steatosis rarely progresses to cirrhosis, 15% to 30% of patients with nonalcoholic steatohepatitis progress to advanced fibrosis, and 12% to 35% with advanced fibrosis progress to cirrhosis

Comparing Ozempic vs Mounjaro , Mounjaro (tirzepatide) uniquely targets both the GLP-1 and GIP receptors, potentially offering more substantial weight reduction than GLP-1RAs that only target the GLP-1 receptor, like Ozempic (semaglutide)

(2025b)

10,44,45 The GSSG is highly toxic since it easily reacts with free sulfhydryl groups from any source